How iCAD Is Using AI to Save Lives Through Earlier Cancer Detection in New Hampshire
iCAD is a Nashua, New Hampshire-based medical AI company with more than 25 years of experience building software that helps radiologists detect cancer earlier and more accurately. Their ProFound AI platform uses deep learning to analyze mammograms, CT colonoscopy images, and other diagnostic scans — flagging suspicious findings that human eyes might miss during a busy day of reads and quantifying the AI's confidence level alongside each finding so radiologists can make faster, better-informed decisions. The clinical AI behind iCAD's products was trained on millions of annotated cases and validated in peer-reviewed studies that consistently show improvements in cancer detection sensitivity without a corresponding increase in false positive callbacks. For radiology practices serving rural and community hospital markets — where radiologist staffing is often stretched thin — iCAD's automation layer effectively gives every practice the reading support of a senior specialist on every case. iCAD is installed in thousands of sites worldwide, and their software has supported the analysis of hundreds of millions of patient scans. With RadNet's acquisition, iCAD gained the distribution reach to accelerate deployment into one of the nation's largest radiology networks while continuing to develop next-generation models. iCAD is among New Hampshire's most consequential tech companies — not because of its valuation, but because of its direct impact on patient outcomes. They are proof that serious, life-saving AI can be built in the Granite State, and their combination of scientific rigor and commercial focus is a model for healthcare AI development nationwide.
If your New Hampshire business serves healthcare providers, radiology practices, or medical technology buyers, this directory puts your brand where their attention already is.